Approval of first-ever medicine for rare blood vessels diseases offers hope ... Canada NewsWire (press release) 1 Today, Roche announced that RITUXAN ® (rituximab), in combination with glucocorticoids, is the first medicine approved by Health Canada for adults with severely active GPA and MPA. "Orphan diseases of this nature are extremely difficult for patients ... |
